This inventor holds 1 USPTO granted patent and 1 published patent application and 7 EPO patents. Top assignee: Adaptate Biotherapeutics Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Robert Good - Innovator in Antibody Development
Introduction
Robert Good is an inventor based in London, GB. He is currently associated with Gammadelta Therapeutics Ltd. His work focuses on the development of innovative antibodies, particularly in the field of immunotherapy.
Latest Patent Applications
Robert Good has filed a patent application titled "ANTI-TCR DELTA VARIABLE 1 ANTIBODIES." This invention provides high-affinity anti-TCR delta variable 1 (anti-Vδ1) antibodies and antibody fragments. The application also includes compositions and pharmaceutical formulations comprising these antibodies, along with methods for their production. Furthermore, it outlines methods of treatment and medical applications involving these antibodies.
Conclusion
Robert Good is making significant contributions to the field of antibody research, particularly through his innovative patent applications. His work has the potential to advance therapeutic options in immunology.